ULTRAMARATHONRT
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98056992
- Registration number
- 7591217
- Mark type
- Stylized text
- Filed
- 23 Jun 2023
- Published for opposition
- 07 May 2024
- Registered
- 03 Dec 2024
- Attorney of record
- Nathan T. Harris
Goods and services
- Class 001 — Chemicals: Enzymes for research purposes; Reagents of reverse transcriptase enzyme for nucleic acid synthesis and amplification for scientific research use; kits comprising reverse transcriptase enzyme for nucleic acid synthesis and amplification for scientific research use
- Class 005 — Pharmaceuticals: enzymes for medical purposes, namely, for clinical purposes; Clinical medical reagents of reverse transcriptase enzyme for nucleic acid synthesis and amplification; kits comprising reverse transcriptase enzyme for medical purposes, namely, for nucleic acid synthesis and amplification for clinical use
Owner
- RNAConnect, Inc., Branford, CT, US
- RNAConnect, Inc., Branford, CT, US
- RNA Connect, Inc., Branford, CT, US
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 21 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Sept 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Jul 2024 — USE AMENDMENT FILED
- 28 Sept 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
- 02 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2024 — PUBLISHED FOR OPPOSITION
- 17 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Mar 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE